MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Madrigal Pharmaceuticals Reports First-Quarter 2026 Financial Results and Provides Corporate Updates
Madrigal Pharmaceuticals Reports First-Quarter 2026 Financial Results and Provides Corporate Updates
Reynolds Consumer Products Reports First Quarter 2026 Financial Results
908 Devices Acquires NIRLAB AG, Expanding Its Narcotics Detection Portfolio
Anavex Life Sciences Board of Directors Appoints Former Senior Vice President of Clinical Development Terrie Kellmeyer, PhD, as Interim Chief Executive Officer
Marex Group plc announces first quarter 2026 results
Nyobolt Closes Series C Round at $1B Valuation, to Power the Rise of Autonomous Machines, Physical AI Applications and AI Data Centers
Spire reports FY26 second quarter results USA - English APAC - Thai APAC - English India - Hindi APAC - Traditional Chinese Korea - 한국어 India - English Vietnam - Vietnamese Indonesia - Bahasa
OTC Markets Group Welcomes Yangarra Resources Ltd. to OTCQX
Insulet Reports First Quarter 2026 Results
Tempest Presents Clinical Update at ISCT 2026 Annual Meeting